In Mumbai, India, on July 7, 2026, Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a prominent global pharmaceutical and wellness firm, unveiled its FY2026 Annual Report. The report focuses on enhancing its worldwide presence and financial investments made during the year.